The life of Cipla, the Indian pharma giant, can broadly be divided into three parts: the first 8 decades of altruistic ...

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

Stay up-to-date with the Grasim Inds Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

India is the third largest startup ecosystem in the world, with over 1.57 lakh certificates issued by DPIIT as of December 31 ...